CreditReports.dk
HomeScreen companies

PHARMCO I ApS Financials, key figures and credit report

CVR number: 25204042 Established 2000 Industry: 64 Financial service activities, except insurance and pension funding
Company contact details
Tinglykke 4-6, Skrydstrup 6500 Vojens
Net sales 571.1 mDKK FY 2025 +4.4% vs 2024
EBIT margin 7.2 % FY 2025 -1.9 pp vs 2024
Net debt - 259.3 mDKK FY 2025 -94.5% vs 2024
Quick ratio 2.1 FY 2025 +0 vs 2024

Income statement (mDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales535.76492.26505.77547.17571.12
Manufacturing for enterprise's own use-3.49-3.59-1.90-2.29-3.04
Other operating income1.612.571.771.782.35
Purchases during the financial year- 106.03-86.55- 114.78- 125.92- 111.19
External services- 139.66- 156.24- 165.47- 169.04- 197.30
Gross profit295.16255.63229.19256.28268.01
Employee benefit expenses- 205.67- 193.16- 177.81- 191.62- 210.93
Other operating expenses-0.03-0.99-0.54
Total depreciation-12.48-13.60-13.56-14.03-15.33
EBIT76.9848.8737.8349.6441.22
Other financial income7.834.1119.9933.00100.25
Other financial expenses-2.88-14.40-6.57-10.85-9.68
Income from other inv. held as non-curr. assets0.010.010.21
Pre-tax profit81.9438.6051.4671.80131.79
Income taxes-17.64-8.67-11.63-15.40-29.61
Net earnings64.3029.9339.8356.40102.18

Assets (mDKK)

2021
2022
2023
2024
2025
Development expenditure1.081.091.462.812.99
Goodwill0.000.080.04
Intangible assets total1.081.091.542.862.99
Land and waters165.31164.75168.05169.39204.36
Buildings11.3210.9712.7513.8326.72
Machinery and equipment23.3822.8921.4319.6121.34
Advance payments and construction in progress2.036.48
Tangible assets total200.02198.61202.24204.86258.91
Investments total
Non-current loans receivable0.010.010.012.022.25
Long term receivables total0.010.010.012.022.25
Semifinished products7.9521.0729.6928.6529.63
Raw materials and consumables37.6251.3546.7442.8438.51
Finished products/goods42.7758.0942.8128.6539.17
Inventories total88.34130.50119.24100.14107.31
Current trade debtors100.5891.9484.3378.4597.31
Prepayments and accrued income1.491.151.281.692.19
Current other receivables61.0939.0638.9625.01-94.75
Current deferred tax assets4.690.920.60
Short term receivables total163.16136.83125.49105.155.34
Other current investments146.1830.90125.52283.81223.38
Cash and bank deposits69.57146.88136.3842.02257.80
Cash and cash equivalents215.75177.77261.90325.83481.18
Balance sheet total (assets)668.36644.82710.42740.86857.98

Equity and liabilities (mDKK)

2021
2022
2023
2024
2025
Share capital0.130.130.130.130.13
Other reserves0.840.851.142.192.33
Retained earnings251.02301.87323.46350.99364.77
Profit of the financial year64.3029.9339.8356.40102.18
Minority interest (BS)80.4775.0766.2761.2274.66
Shareholders equity total396.75407.85430.83470.92544.08
Provisions17.4720.6521.9519.8724.84
Non-current loans from credit institutions53.7351.0748.4145.7262.15
Non-current liabilities total53.7351.0748.4145.7262.15
Current loans from credit institutions80.7390.86151.43146.28159.17
Current trade creditors27.2324.0726.4019.3635.08
Current owed to participating0.440.380.530.560.60
Short-term deferred tax liabilities3.462.901.97
Other non-interest bearing current liabilities88.5349.9430.8835.2530.09
Current liabilities total200.40165.25209.23204.35226.92
Balance sheet total (liabilities)668.36644.82710.42740.86857.98
Page generated